These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 8782086

  • 21. Three-dimensional quantitative structure-activity relationship study of nonsteroidal estrogen receptor ligands using the comparative molecular field analysis/cross-validated r2-guided region selection approach.
    Sadler BR, Cho SJ, Ishaq KS, Chae K, Korach KS.
    J Med Chem; 1998 Jun 18; 41(13):2261-7. PubMed ID: 9632359
    [Abstract] [Full Text] [Related]

  • 22. Use of the yeast one-hybrid system to screen for mutations in the ligand-binding domain of the estrogen receptor.
    Bush SM, Folta S, Lannigan DA.
    Steroids; 1996 Mar 18; 61(3):102-9. PubMed ID: 8852826
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A HOXA10 estrogen response element (ERE) is differentially regulated by 17 beta-estradiol and diethylstilbestrol (DES).
    Akbas GE, Song J, Taylor HS.
    J Mol Biol; 2004 Jul 23; 340(5):1013-23. PubMed ID: 15236964
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
    Kim S, Brown PH, Birrer MJ.
    Oncogene; 1996 Mar 07; 12(5):1043-53. PubMed ID: 8649795
    [Abstract] [Full Text] [Related]

  • 27. Determinants of ligand specificity of estrogen receptor-alpha: estrogen versus androgen discrimination.
    Ekena K, Katzenellenbogen JA, Katzenellenbogen BS.
    J Biol Chem; 1998 Jan 09; 273(2):693-9. PubMed ID: 9422719
    [Abstract] [Full Text] [Related]

  • 28. A human estrogen receptor (ER)alpha mutation with differential responsiveness to nonsteroidal ligands: novel approaches for studying mechanism of ER action.
    Paulmurugan R, Tamrazi A, Katzenellenbogen JA, Katzenellenbogen BS, Gambhir SS.
    Mol Endocrinol; 2008 Jul 09; 22(7):1552-64. PubMed ID: 18451095
    [Abstract] [Full Text] [Related]

  • 29. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor.
    Pakdel F, Reese JC, Katzenellenbogen BS.
    Mol Endocrinol; 1993 Nov 09; 7(11):1408-17. PubMed ID: 8114756
    [Abstract] [Full Text] [Related]

  • 30. A triple mutant of the Drosophila ERR confers ligand-induced suppression of activity.
    Ostberg T, Jacobsson M, Attersand A, Mata de Urquiza A, Jendeberg L.
    Biochemistry; 2003 Jun 03; 42(21):6427-35. PubMed ID: 12767224
    [Abstract] [Full Text] [Related]

  • 31. Characterization of a temperature-sensitive mutation in the hormone binding domain of the human estrogen receptor. Studies in cell extracts and intact cells and their implications for hormone-dependent transcriptional activation.
    Reese JC, Katzenellenbogen BS.
    J Biol Chem; 1992 May 15; 267(14):9868-73. PubMed ID: 1577818
    [Abstract] [Full Text] [Related]

  • 32. William L. McGuire Memorial Symposium. Estrogen receptors: ligand discrimination and antiestrogen action.
    Katzenellenbogen BS, Fang H, Ince BA, Pakdel F, Reese JC, Wooge CH, Wrenn CK.
    Breast Cancer Res Treat; 1993 May 15; 27(1-2):17-26. PubMed ID: 8260727
    [Abstract] [Full Text] [Related]

  • 33. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
    Weis KE, Ekena K, Thomas JA, Lazennec G, Katzenellenbogen BS.
    Mol Endocrinol; 1996 Nov 15; 10(11):1388-98. PubMed ID: 8923465
    [Abstract] [Full Text] [Related]

  • 34. FLP recombinase/estrogen receptor fusion proteins require the receptor D domain for responsiveness to antagonists, but not agonists.
    Nichols M, Rientjes JM, Logie C, Stewart AF.
    Mol Endocrinol; 1997 Jun 15; 11(7):950-61. PubMed ID: 9178754
    [Abstract] [Full Text] [Related]

  • 35. Bivalent ligands as probes of estrogen receptor action.
    Bergmann KE, Wooge CH, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA.
    J Steroid Biochem Mol Biol; 1994 Jun 15; 49(2-3):139-52. PubMed ID: 8031710
    [Abstract] [Full Text] [Related]

  • 36. Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha.
    Kim JH, Lee MH, Kim BJ, Kim JH, Han SJ, Kim HY, Stallcup MR.
    J Mol Endocrinol; 2005 Dec 15; 35(3):449-64. PubMed ID: 16326832
    [Abstract] [Full Text] [Related]

  • 37. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta.
    Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguère V.
    Mol Endocrinol; 1997 Mar 15; 11(3):353-65. PubMed ID: 9058381
    [Abstract] [Full Text] [Related]

  • 38. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
    Gee AC, Carlson KE, Martini PG, Katzenellenbogen BS, Katzenellenbogen JA.
    Mol Endocrinol; 1999 Nov 15; 13(11):1912-23. PubMed ID: 10551784
    [Abstract] [Full Text] [Related]

  • 39. Diethylstilbestrol metabolites and analogs. Biochemical probes for differential stimulation of uterine estrogen responses.
    Korach KS, Fox-Davies C, Quarmby VE, Swaisgood MH.
    J Biol Chem; 1985 Dec 15; 260(29):15420-6. PubMed ID: 4066677
    [Abstract] [Full Text] [Related]

  • 40. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
    Montano MM, Müller V, Trobaugh A, Katzenellenbogen BS.
    Mol Endocrinol; 1995 Jul 15; 9(7):814-25. PubMed ID: 7476965
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.